Play all audios:
To control antimicrobial resistance (AMR) will require approaches to develop, share and preserve antibiotics that are scaled to the scientific, economic and ethical dimensions of the crisis.
The three cooperative, interdisciplinary, international councils proposed here exemplify what this will require. Access through your institution Buy or subscribe This is a preview of
subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value
online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more
Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS:
* Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Roope, L. S. J. et al. The challenge of antimicrobial resistance: what economics
can contribute. _Science_ 364, eaau4679 (2019). Article CAS Google Scholar * The Review on Antimicrobial Resistance. _Tackling drug-resistant infections globally: final report and
recommendations_. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (2016). * Nathan, C. & Cars, O. Antibiotic resistance — problems, progress, and
prospects. _N. Engl. J. Med._ 371, 1761–1763 (2014). Article Google Scholar * Laxminarayan, R., Sridhar, D., Blaser, M., Wang, M. & Woolhouse, M. Achieving global targets for
antimicrobial resistance. _Science_ 353, 874–875 (2016). Article CAS Google Scholar * Nathan, C. Aligning pharmaceutical innovation with medical need. _Nat. Med._ 13, 304–308 (2007).
Article CAS Google Scholar * Nielsen, T. B., Brass, E. P., Gilbert, D. N., Bartlett, J. G. & Spellberg, B. Sustainable discovery and development of antibiotics - is a nonprofit
approach the future? _N. Engl. J. Med._ 381, 503–505 (2019). Article Google Scholar * Outterson, K. et al. Delinking investment in antibiotic research and development from sales revenues:
the challenges of transforming a promising idea into reality. _PLoS Med._ 13, e1002043 (2016). Article Google Scholar * Årdal, C. et al. _Drive-AB Report. Revitalizing the antibiotic
pipeline_. http://drive-ab.eu/wp-content/uploads/2018/01/DRIVE-AB-Final-Report-Jan2018.pdf (2018). * Barbier, E. Sustainability: tax ‘societal ills’ to save the planet. _Nature_ 483, 30
(2012). Article CAS Google Scholar * Nathan, C. F. Cooperative development of antimicrobials: looking back to look ahead. _Nat. Rev. Microbiol._ 13, 651–657 (2015). Article CAS Google
Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Weill Cornell Medicine, New York, USA Carl Nathan Authors * Carl Nathan View author publications You can also
search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Carl Nathan. ETHICS DECLARATIONS COMPETING INTERESTS The author declares no competing interests.
ADDITIONAL INFORMATION RELATED LINKS COMBATING ANTIBIOTIC RESISTANT BACTERIA BIOPHARMACEUTICAL ACCELERATOR (CARB-X): https://carb-x.org GLOBAL ANTIBIOTIC RESEARCH AND DEVELOPMENT PARTNERSHIP
(GARDP): https://www.gardp.org RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Nathan, C. Resisting antimicrobial resistance. _Nat Rev Microbiol_ 18,
259–260 (2020). https://doi.org/10.1038/s41579-020-0348-5 Download citation * Published: 16 April 2020 * Issue Date: May 2020 * DOI: https://doi.org/10.1038/s41579-020-0348-5 SHARE THIS
ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative